Literature DB >> 3900635

Preparation of antibody-toxin conjugates.

A J Cumber, J A Forrester, B M Foxwell, W C Ross, P E Thorpe.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3900635     DOI： 10.1016/s0076-6879(85)12018-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  21 in total

1.  Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery.

Authors:  Deirdre P McIntosh; Xiang-Yang Tan; Phil Oh; Jan E Schnitzer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

2.  Specific interaction between GroEL and denatured protein measured by compression-free force spectroscopy.

Authors:  Hiroshi Sekiguchi; Hideo Arakawa; Hideki Taguchi; Takeshi Ito; Ryohei Kokawa; Atsushi Ikai
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

3.  Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.

Authors:  E J Derbyshire; R A Stahel; E J Wawrzynczak
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.

Authors:  E J Wawrzynczak; E J Derbyshire; R V Henry; G D Parnell; A Smith; R Waibel; R A Stahel
Journal:  Br J Cancer Suppl       Date:  1991-06

5.  Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.

Authors:  E J Derbyshire; E J Wawrzynczak
Journal:  Br J Cancer Suppl       Date:  1991-06

6.  Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.

Authors:  E J Wawrzynczak; G J Watson; A J Cumber; R V Henry; G D Parnell; E P Rieber; P E Thorpe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Development of a bifunctional crosslinking agent with potential for the preparation of immunotoxins.

Authors:  J A McKenzie; R L Raison; D E Rivett
Journal:  J Protein Chem       Date:  1988-10

8.  The carriage and delivery of substances to lymphatic tissues by recirculating lymphocytes. I. The concentration of ricin in lymphocyte traffic areas.

Authors:  S M Sparshott; J A Forrester; D P McIntosh; C Wood; A J Davies; W L Ford
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

9.  Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.

Authors:  R Xing; R W Mason
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  A modified spectroscopic method for the determination of the transbilayer distribution of phosphatidylethanolamine in soya-bean asolectin small unilamellar vesicles.

Authors:  P Sarti; A Molinari; G Arancia; A Meloni; G Citro
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.